Over half of India’s top Nifty50 stocks are now trading at lower forward P/E multiples than in 2023, indicating a significant valuation correction. This discount sale, driven by macro anxieties and a slowdown in earnings growth, presents a recalibrated risk-reward scenario for investors. Experts suggest this period offers a tactical accumulation window for long-term capital allocators.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO